Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The BDNF Val66Met polymorphism might be implicated in the pathogenesis of depression in T2DM by decreasing serum BDNF levels in Han Chinese Subjects. 23968401

2013

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Two recent papers associated candidate genes with brooding rumination, a possible cognitive endophenotype for depression, in children ages 8-14 years.Stone et al. reported that BDNF val66met polymorphism predicted brooding in adolescence.Woody et al. reported that children carrying at least one copy of a CRHR1 TAT haplotype reported less brooding than their peers in the presence of maternal depression. 27073970

2017

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression. 26462036

2015

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE In the total sample, the BDNF Val66Met polymorphism was not significantly associated with depression. 18852698

2010

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Six functional SNPs in genes related to the serotonergic system were examined: serotonin transporter (5HTTLPR including rs25531), 5HT1A C-(1019)G and 5HT2A T-(102)C, methylene tetrahydrofolate reductase (MTHFR) C-(677)T, brain-derived neurotrophic factor (BDNF) val66met and tryptophan hydroxylase-2 (TPH2) G-(703)T. Regression analyses were performed using the six SNPs as independent variables: Model 1 with response (percentage Hamilton Depression (HAMD) change from baseline to endpoint) as the dependent variable and Model 2 with adverse event index as the dependent variable (Bonferroni corrected p-value < 0.025). 20515362

2010

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE In 732 Korean community residents ages 65+, diagnosis of depression (Geriatric Mental State Schedule), information on SLEs, and genotypes for 5-HTTLPR and BDNF val66met were ascertained. 17482146

2007

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE This study was to examine the chronic stress × BDNF Val66Met</span> interaction in job-related depression in the healthcare workers in a Chinese Han population, which has not been reported yet. 29734099

2018

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Given that BDNF secretion is affected by a common polymorphism (rs6265, Val66Met), which also is associated with depression, we investigated whether this polymorphism modifies the effect of childhood adversity (CA) on local gray matter (GM) volume in depression-relevant brain regions, using data from two large cohorts of healthy subjects. 21577214

2012

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE According to this rationale, we investigated the role of two functional polymorphisms in the genes coding for the serotonin transporter (5-HTTLPR) and the brain-derived neurotrophic factor (BDNF Val66Met), and rTMS response in a group of 36 drug resistant patients affected by mood disorders. rTMS treatment significantly improved depression symptomatology (p<0.0001) and the response was significantly greater in 5-HTTLPR LL homozygotes compared to S allele carriers (p=0.007) and in BDNF Val/Val homozygotes compared to Met allele carriers (p=0.024). 18450378

2008

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Our objectives were to: 1) compare plasma BDNF levels in medicated patients with depression and controls; 2) assess the effect of ECT on plasma BDNF levels in medicated patients with depression; 3) explore the relationship between plasma BDNF levels and the Val66Met (rs6265) BDNF polymorphism; and 4) examine the relationship between plasma BDNF levels and clinical symptoms and outcomes with ECT. 29802070

2019

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The results suggest that interactions may occur after stresses among BDNF Val66Met, gender and time course to influence dep</span>ression. 28527683

2017

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE These results indicate that there was a lack of association between severity of depression and BDNF Val66Met polymorphism in Chinese patients with MDD. 20016225

2010

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Childhood adversity showed an interaction with the brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism, serotonin transporter-linked promoter region (5-HTTLPR), and FK506 binding protein 51 (FKBP5) gene rs1360780 in brain morphologic changes in patients with depression and in a non-clinical population. 29535036

2019

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The val66met variant located within the brain-derived neurotrophic factor gene (BDNF) has previously been associated with human neuroticism, a dimension of personality strongly predictive of depressive illness. 16043130

2005

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. 18263664

2008

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The serotonin transporter polymorphism (5-HTTLPR) and the brain-derived neurotrophic factor (BDNF) val66met polymorphism have both been linked to depression symptoms and to depression diagnosis (MDD) in interaction with adversity; there have also been failures to find the effects. 21420735

2011

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE I will also review key studies, both human and animal, which have investigated the association of a BDNF single-nucleotide polymorphism (Val66Met) with depression pathogenesis, and detail the number of inconsistencies which also afflict this novel area of BDNF research. 17700574

2007

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The single nucleotide polymorphism (Val66Met), which has been shown to have functional and behavioral effects, was genotyped in 284 depressed participants and 331 controls, showing association with depression (P=0.005). 17632285

2007

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Higher order interaction effects involving BDNF Val(66)Met, 5-HTTLPR and childhood adversity may contribute to the etiology of depressive illness. 17579366

2008

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The brain-derived neurotrophic factor (BDNF) Val66Met single nucleotide polymorphism may be associated with clinical and subsyndromal depression, but physical activity improves mood and increases BDNF expression. 24745471

2014

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE Plasma brain-derived neurotrophic factor (BDNF) concentration and the <i>BDNF</i> Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder. 31308724

2019

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The results suggest that in males, BDNF Val66Met interacts with childhood life events, increasing the cognitive susceptibility markers of depression. 22033217

2012

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE A multivariable linear regression model showed that the best predictors of depression were the SF-36 General health (β = -0.209; P = 0.013), Mental health (β = -0.410; P < 0.001) and Social activity (β = -0.195; P = 0.035) scores; physical disability (assessed by the Extended Disability Status Scale score) was directly correlated to depression severity on univariate analysis, but it was not a relevant predictor of depression on multivariate analysis; other variables directly related to the disease (treatment, annual relapsing rate) and the BDNF Val66Met polymorphism were not significantly associated with depression. 26756166

2016

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE The authors hypothesize that other factors may have a stronger effect on hippocampal structure in older individuals and that the association between the Val66Met polymorphism and geriatric depression is mediated through other mechanisms. 20220593

2010

dbSNP: rs759834365
rs759834365
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.100 GeneticVariation BEFREE This study aimed to investigate whether BDNF gene promoter methylation status and val66met polymorphism were associated with depression ascertained at two weeks and one year after stroke. 23399480

2013